- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Oxygenta Pharmaceutical Ltd — Board Meeting, 27-07-2026: Board Meeting
27-07-2026 | 06:05 pm
27-07-2026 | 06:05 pm
Oxygenta Pharma's board approved Q1 FY27 results: Revenue soared to ₹37 Cr (up from ₹15.13 Cr YoY), while net loss significantly narrowed to ₹2.10 Cr (from ₹6.11 Cr). AGM is set for August 21, 2026. New Cost Auditors appointed. Company secured 399 Lakhs via ECLGS.
No comments yet. Be the first to comment!